Biotech Earnings: What Investors Should Watch Before the Call
Biotech earnings are different from earnings in many other sectors because the most important signals are often not the revenue line. For many biotechnology companies, the earnings release is more valuable as a catalyst update than as a pure financial report. Investors use it to understand cash runway, upcoming trial milestones, regulatory timing, commercial traction, and management confidence in the pipeline.